首页> 外文会议>World biomaterials congress >Self-assembling peptide scaffolds support human embryonic stem cell-derived cortical transplants in a model of stroke
【24h】

Self-assembling peptide scaffolds support human embryonic stem cell-derived cortical transplants in a model of stroke

机译:在中风模型中,自组装肽支架支持人胚胎干细胞衍生的皮质移植

获取原文

摘要

Brain injury results in neuronal loss and disruption of the brain parenchyma. However, the pathology of brain injury is not only dictated by the initial insult, but there is a significant secondary injury caused by a subsequent inflammatory response, which includes astrocytes becoming reactive and proliferating locally. Therefore, the current neurological problem is to attenuate the inflammatory response of the injured brain to promote the long-term survival of neurones and circuitry reconstruction. However, preventing secondary injury alone will not be adequate to promote brain repair, as neuroprotection within the penumbra will be required immediately following tissue insult with control over the inflammatory cascade promoting their long term survival. Ultimately, repair post brain injury will depend on: (a) restoring the architecture of damaged tissue; (b) transplanting replacement cells into the injury site; (c) providing a suitable microenvironment for transplanted cells to interegrate with the host and (d) to support surviving cells within the penumbra. Fmoc-DDIKVAV was synthesised using solid-phase peptide synthesis. Hydrogels were formed via a pH switch at a concentration of 10mg/ml and were characterised by Rheology, Fourier Transform Infrared Spectroscopy, Circular dichroism and Transmission Electron Microscopy confirmed the self-assembly of Fmoc-DDIKVAV. The stroke model was achieved by stereotaxically inject human ET-1 peptide (800pmol in 1mL) into the frontal, motor cortex of rats to cause vasoconstriction and focal necrotic cell death. hESC due to it being a sustainable source, the ability to standardize the donor material (unlike fetally-derived tissue), availability of GFP+ reporter lines and relevance to future clinical application. We will differentiate GFP+ human embryonic stem cells (hESCs) into forebrain cortical progenitors. Differentiated GFP+ cells (100,000 cells in 1mL) will be grafted into the cystic lesion cavity. The grafts where characterised by assessing behaviour, cortical atrophy and using immunocytohistochemistry. Here, we have shown that the trasplanting hESC derived neural progenitor cells (NPCs) concomidently with our Fmoc-DDIKVAV hydrogel across the necrotic lesion cavity, provided both physical and trophic support to transplanted cells, as well as for host cells withing the penumbra. The self-assembling peptide scaffolds were shown to significantly improve the survival and integration of the transplanted cells, along with a significant reduction in secondary degeneration caused by reactive astrocytosis. hESC derived NPCs that were transplanted within our Fmoc-DDIKVAV hydrogels, showed enhanced behavioural recovery along with increased functional maturity over a 9 month period, compared to cell grafts alone control group. While the focus of this study was on repairing the injured brain, our biologically relevant hydrogels have broader implications for the exploitation in areas such as cancer therapy, muscle and bone regeneration to name a few. Fig. 1 - Shows the integration and reinnervation of transplanted hESC dertived NPCs within a Fmoc-DDIKVAV hydrogel.
机译:脑损伤导致神经元缺失和脑实质破坏。然而,脑损伤的病理不仅由初始损伤决定的,但存在由随后的炎症反应,其包括星形胶质细胞的反应性变得并局部增殖一个显著继发性损伤。因此,目前的神经问题是衰减受伤大脑的炎症反应,以促进神经元和电路重建的长期存活。然而,仅仅防止继发性损伤是不足以促进大脑修复,如半影内神经保护将被要求立即在炎症级联促进其长期生存控制组织损伤以下。最终,后修复脑损伤将取决于:(一)恢复受损组织架构; (B)移植替代细胞到损伤位点; (c)对于移植细胞与主机和(d)interegrate提供合适的微环境,以支持半影内的存活细胞。将Fmoc-DDIKVAV使用固相肽合成法合成。水凝胶在为10mg / ml的浓度经由的pH开关形成和表征由Rheology,傅里叶变换红外光谱,圆二色性和透射电子显微镜证实了自组装的Fmoc-DDIKVAV的。行程模型是由立体定向注射人ET-1的肽(1毫升在800pmol)到大鼠的前,运动皮质到引起血管收缩和局灶性坏死性细胞死亡来实现。人类胚胎干细胞,由于它是一种可持续源,以规范的供体材料(不像fetally来源的组织)的能力,对GFP +记者线的可用性和相关性的未来的临床应用。我们将区分GFP +人类胚胎干细胞(hESC)到前脑皮层祖细胞。分化的GFP +细胞(100,000个细胞在1mL中)将被嫁接到的囊性病变腔。其中特点是评估行为,皮质萎缩和使用immunocytohistochemistry的移植。在这里,我们已经表明,人类胚胎干细胞trasplanting衍生的神经祖细胞(NPC)concomidently与我们在整个病变坏死腔的Fmoc-DDIKVAV水凝胶,提供了一种用于宿主细胞withing半影到移植的细胞的物理和营养支持,以及。的自组装肽的支架显示出显著提高移植细胞的存活和整合,以引起活性星形细胞增生在次级变性显著减少沿。人类胚胎干细胞衍生的移植提供了将Fmoc-DDIKVAV水凝胶内,显示出与在9个月内增加功能成熟沿着增强行为恢复的NPC,相比于细胞移植物单独对照组。虽然这项研究的重点是修复脑损伤,我们的生物相关水凝胶具有对诸如癌症治疗,肌肉和骨再生仅举几方面的开发更广泛的影响。图1 - 显示集成和移植的hESC的神经支配恢复dertived一个的Fmoc-DDIKVAV水凝胶内的NPC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号